IP that matters: behind Orexo’s patent win against generic giant (NLS Days)

IP that matters: behind Orexo’s patent win against generic giant (NLS Days)
date
October 13, 2025
TIme
16:30 - 17:30 CEST
Address

Flow Stage, Svenska Mässan, Gothenburg

When a challenger comes for your life’s work, how do you fight back and win?

At Nordic Life Science Days, you’ll get a rare inside look at Orexo’s decisive US patent litigation victory over Sun Pharma, a case that proves the power of a rock-solid IP strategy in protecting both innovation and patient impact. 

Hear from those who lived it: 

  • Orexo – on the effective use of IP to meet its business objectives, safeguarding lifechanging treatments for opioid dependence; 
  • Steptoe -  US litigators who brought and successfully argued the case before the court; and
  • Potter Clarkson – Orexo’s patent attorneys who had a key, central role in preparing the ground for that success

Join us on the Flow Stage at 16:30, Monday 13 October for an insightful session.

Because when innovation is under fire, strategy is everything. 

Latest News

Creating an effective IP strategy for CAR-T

Creating an effective IP strategy for CAR-T

When is a synbio company a gene therapy company?

When is a synbio company a gene therapy company?

IAM Patent 1000: The World's Leading Patent Professionals 2026

IAM Patent 1000: The World's Leading Patent Professionals 2026

PCOS name changes to PMOS: Will PCOS’ name change impact patent applications

PCOS name changes to PMOS: Will PCOS’ name change impact patent applications

Drug repurposing in the age of AI: lessons from COVID-19 and the future of second medical use innovation

Drug repurposing in the age of AI: lessons from COVID-19 and the future of second medical use innovation

How to file an opposition at the European Patent Office (EPO)

How to file an opposition at the European Patent Office (EPO)

Of a Dame and the King (of Beer): when an indefinite trade mark licence can end

Of a Dame and the King (of Beer): when an indefinite trade mark licence can end

Process patents, product patents, or trade secrets? Choosing the right IP strategy in chemical manufacturing

Process patents, product patents, or trade secrets? Choosing the right IP strategy in chemical manufacturing

See All News